Wird geladen...
Implications of bevacizumab discontinuation in adults with recurrent glioblastoma
BACKGROUND: Patients with recurrent glioblastoma benefiting from bevacizumab are often treated indefinitely due to concerns regarding rebound tumor recurrence upon discontinuation. However, treatment is discontinued for reasons other than disease progression in a subset of these patients, the charac...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4022226/ https://ncbi.nlm.nih.gov/pubmed/24596117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou021 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|